The efficacy and safety of desmopressin in the treatment of adults with nocturia have been assessed in several randomized trials, but few information exist on its application in patients affected by Parkinson's disease (PD) or Multiple Sclerosis (MS). The aim of the present study was to investigate the efficacy and safety of desmopressin administration in PD and MS patients affected by nocturia, in a medium term follow up.
Giannantoni, A., M., G., J. A., R.D.V., R., B., S., P. (2014). Desmopressin in the treatment of nocturia in patients affected by neurogenic bladder. EUROPEAN UROLOGY. SUPPLEMENTS, 13(1), e771-e771a [10.1016/S1569-9056(14)60759-4].
Desmopressin in the treatment of nocturia in patients affected by neurogenic bladder
GIANNANTONI, Antonella;
2014-01-01
Abstract
The efficacy and safety of desmopressin in the treatment of adults with nocturia have been assessed in several randomized trials, but few information exist on its application in patients affected by Parkinson's disease (PD) or Multiple Sclerosis (MS). The aim of the present study was to investigate the efficacy and safety of desmopressin administration in PD and MS patients affected by nocturia, in a medium term follow up.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Desmopressin.pdf
non disponibili
Tipologia:
PDF editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
205.75 kB
Formato
Adobe PDF
|
205.75 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1065917